Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
作者信息
Armitage J, Collins R
出版信息
Heart. 2000 Oct;84(4):357-60. doi: 10.1136/heart.84.4.357.
Abstract
摘要
相似文献
1
Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.糖尿病患者降低低密度脂蛋白胆固醇所需的大规模随机证据：医学研究委员会/英国心脏基金会心脏保护研究及其他主要试验
Heart. 2000 Oct;84(4):357-60. doi: 10.1136/heart.84.4.357.
2
[Not Available].[无可用内容]。
Ther Umsch. 2017;74(8):445-453. doi: 10.1024/0040-5930/a000939.
3
After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?FIELD研究之后：贝特类药物应用于预防糖尿病患者心血管疾病是否合理？
Lancet. 2005 Nov 26;366(9500):1829-31. doi: 10.1016/S0140-6736(05)67668-4.
4
[Lipid management--treatment goal and strategy].[血脂管理——治疗目标与策略]
Nihon Rinsho. 2006 Nov;64(11):2102-6.
5
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.超越低密度脂蛋白：应对2型糖尿病和代谢综合征中的致动脉粥样硬化脂质三联征。
Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005.
6
Lipid management for cardiovascular risk reduction in type 1 diabetes.1 型糖尿病患者的心血管风险降低的血脂管理。
Curr Opin Endocrinol Diabetes Obes. 2020 Aug;27(4):207-214. doi: 10.1097/MED.0000000000000551.
7
PCSK9 inhibitors- A new age in lipid management?前蛋白转化酶枯草溶菌素9抑制剂——脂质管理的新时代？
Diab Vasc Dis Res. 2017 May;14(3):171. doi: 10.1177/1479164117708122.
8
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.他汀类药物14项随机试验中18686例糖尿病患者降脂治疗的疗效：一项荟萃分析。
Lancet. 2008 Jan 12;371(9607):117-25. doi: 10.1016/S0140-6736(08)60104-X.
9
Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.医学降脂治疗：当前证据、正在进行的试验及未来发展
Drugs. 2004;64(11):1181-96. doi: 10.2165/00003495-200464110-00003.
10
[Lipid therapy in patients with diabetes].[糖尿病患者的脂质治疗]
Wien Med Wochenschr. 2010 Jan;160(1-2):25-9. doi: 10.1007/s10354-010-0745-x.
引用本文的文献
1
Statin Prescription Patterns and Associated Factors Among Patients with Type 2 Diabetes Mellitus Attending Diabetic Clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania.坦桑尼亚达累斯萨拉姆市穆希姆比利国家医院糖尿病诊所2型糖尿病患者的他汀类药物处方模式及相关因素
Diabetes Metab Syndr Obes. 2022 Feb 27;15:633-646. doi: 10.2147/DMSO.S347765. eCollection 2022.
2
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.抗氧化剂补充剂对健康参与者及各类疾病患者死亡率的预防作用
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD007176. doi: 10.1002/14651858.CD007176.pub2.
3
Treatment of hypertension in metabolic syndrome: implications of recent clinical trials.代谢综合征中高血压的治疗：近期临床试验的启示
Curr Diab Rep. 2009 Jun;9(3):229-37. doi: 10.1007/s11892-009-0037-2.
4
Antioxidant supplements for preventing gastrointestinal cancers.用于预防胃肠道癌症的抗氧化剂补充剂。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD004183. doi: 10.1002/14651858.CD004183.pub3.
5
Hypertension in people with diabetes and the metabolic syndrome: pathophysiologic insights and therapeutic update.糖尿病和代谢综合征患者的高血压：病理生理学见解与治疗进展
Curr Diab Rep. 2007 Jun;7(3):208-17. doi: 10.1007/s11892-007-0033-3.
6
The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393].辛伐他汀降低胆固醇对20536名高危人群特定病因死亡率和癌症发病率的影响：一项随机安慰剂对照试验[国际标准随机对照试验编号：ISRCTN48489393]
BMC Med. 2005 Mar 16;3:6. doi: 10.1186/1741-7015-3-6.
7
[Tackling lipaemia in diabetes mellitus in primary care].[在初级保健中应对糖尿病患者的血脂异常]
Aten Primaria. 2003;32(4):240-52. doi: 10.1016/s0212-6567(03)79258-0.
8
Diabetic dyslipidaemia: from basic research to clinical practice.糖尿病血脂异常：从基础研究到临床实践
Diabetologia. 2003 Jun;46(6):733-49. doi: 10.1007/s00125-003-1111-y. Epub 2003 May 28.
9
Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes.
Curr Diab Rep. 2002 Jun;2(3):269-73. doi: 10.1007/s11892-002-0094-2.
Zotero 插件